Results 21 to 30 of about 273,777 (285)

Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery

open access: yesNature Communications, 2020
CRISPR/Cas9 technology has revolutionised the ability of scientists to make genetically modified cells and animal models. Here, the authors make a Tet-On genetically modified mouse using the Streptococcus pyogenes Cas9 and demonstrate that it can be used
Anders Lundin   +23 more
doaj   +1 more source

Genetically modified mice for research on human diseases: A triumph for Biotechnology or a work in progress?

open access: yesThe EuroBiotech Journal, 2022
Genetically modified mice are engineered as models for human diseases. These mouse models include inbred strains, mutants, gene knockouts, gene knockins, and ‘humanized’ mice.
Brown Richard E.
doaj   +1 more source

CRISPR/Cas9‐mediated genome editing: from basic research to translational medicine [PDF]

open access: yes, 2020
The recent development of the CRISPR/Cas9 system as an efficient and accessible programmable genome-editing tool has revolutionized basic science research. CRISPR/Cas9 system-based technologies have armed researchers with new powerful tools to unveil the
Ferreira, B I   +2 more
core   +1 more source

QPCTL regulates macrophage and monocyte abundance and inflammatory signatures in the tumor microenvironment

open access: yesOncoImmunology, 2022
The enzyme glutaminyl-peptide cyclotransferase-like protein (QPCTL) catalyzes the formation of pyroglutamate residues at the NH2-terminus of proteins, thereby influencing their biological properties.
Kaspar Bresser   +8 more
doaj   +1 more source

Functional genetic dropout screens and in vivo validation of candidate therapeutic targets using mouse mammary tumoroids

open access: yesSTAR Protocols, 2022
Summary: We have previously developed 3D tumoroids derived from genetically engineered mouse models (GEMMs) of BRCA1/2-deficient breast cancer. Here, we describe how to genetically modify tumoroids, use them for functional genetic dropout screens, and ...
Mariana Paes Dias   +2 more
doaj   +1 more source

Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma. [PDF]

open access: yes, 2015
Adamantinomatous craniopharyngiomas (ACPs) are the most common pituitary tumours in children. Although histologically benign, these are clinically aggressive tumours, difficult to manage and associated with poor quality of life for the patients.
Martinez-Barbera, JP
core   +1 more source

A Simple and Fast Battery Test for Phenotypic Characterization of Mice

open access: yesBio-Protocol, 2020
Despite the great number of test batteries already known to assess the behavior of genetically modified and inbred strains of mice, only a few of them focus on basic neurological parameters.
Mariana Garcia-Gomes   +11 more
doaj   +1 more source

Mice in ecstasy : advanced animal models in the study of MDMA [PDF]

open access: yes, 2010
The party drug 3,4-methylenedioxymethamphetamine -better known as MDMA or ecstasy- has numerous effects on the human body, characterized by a rush of energy, euphoria and empathy.
Stove, Christophe   +3 more
core   +2 more sources

The Role of Insulin-like Growth Factor-1 (IGF-1) in the Control of Neuroendocrine Regulation of Growth

open access: yesCells, 2021
In mammals, the neuroendocrine system, which includes the communication between the hypothalamus and the pituitary, plays a major role in controlling body growth and cellular metabolism. GH produced from the pituitary somatotroph is considered the master
Sarmed Al-Samerria, Sally Radovick
doaj   +1 more source

DEVELOPMENT OF MURINE STEM CELLS WITH CONDITIONAL KNOCKOUT OF HUMANIZED SNCA GENE

open access: yesФармация и фармакология (Пятигорск), 2023
α-synuclein is one of the key molecular links in the pathogenesis of Parkinson’s disease. The accumulated data indicate that pathogenic mutations in the Snca gene are associated with the development of neurodegenerative brain damage, indicating the ...
E. A. Patrakhanov   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy